Search research articles
Contact Us
Filters
Showing results (1-10 of 72) with videos related to
Page
of 8
Sort By:
Journal of Clinical & Cellular Immunology
|
July 26, 2016
Th17 Cells in Protection from Tumor or Promotion of Tumor Progression
M Rita I Young
Cancer Letters
|
January 29, 2017
Redirecting the focus of cancer immunotherapy to premalignant conditions
M Rita I Young
International Journal of Molecular Sciences
|
January 14, 2017
Cancer Immunology with a Focus on Understudied Cancers as Targets for Immunotherapy
M Rita I Young
Head & Neck
|
November 15, 2005
Protective mechanisms of head and neck squamous cell carcinomas from immune assault
M Rita I Young
International Journal of Cancer
|
February 2, 2006
Cytokine-containing gelfoam implants at a postsurgical tumor excision site to stimulate local immune reactivity
M Rita I Young
Cancer Immunology, Immunotherapy : CII
|
November 25, 2003
Trials and tribulations of immunotherapy as a treatment option for patients with squamous cell carcinoma of the head and neck
M Rita I Young
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
May 16, 2008
Use of carcinogen-induced premalignant oral lesions in a dendritic cell-based vaccine to stimulate immune reactivity against both premalignant oral lesions and oral cancer
M Rita I Young
Angiogenesis
|
November 2, 2004
Tumor-derived prostaglandin E2 and transforming growth factor-beta stimulate endothelial cell motility through inhibition of protein phosphatase-2A and involvement of PTEN and phosphatidylinositide 3-kinase
M Rita I Young
International Journal of Cancer
|
March 3, 2004
Tumor skewing of CD34+ progenitor cell differentiation into endothelial cells
M Rita I Young
Trends in Cancer Research
|
October 30, 2018
Influence of vitamin D on cancer risk and treatment: Why the variability?
M Rita I Young, Ying Xiong
Page
of 8
Search research articles
Search
Showing results (1-10 of 72) with videos related to
Sort By:
Page
of 8
Journal of Clinical & Cellular Immunology
|
July 26, 2016
Th17 Cells in Protection from Tumor or Promotion of Tumor Progression
M Rita I Young
Cancer Letters
|
January 29, 2017
Redirecting the focus of cancer immunotherapy to premalignant conditions
M Rita I Young
International Journal of Molecular Sciences
|
January 14, 2017
Cancer Immunology with a Focus on Understudied Cancers as Targets for Immunotherapy
M Rita I Young
Head & Neck
|
November 15, 2005
Protective mechanisms of head and neck squamous cell carcinomas from immune assault
M Rita I Young
International Journal of Cancer
|
February 2, 2006
Cytokine-containing gelfoam implants at a postsurgical tumor excision site to stimulate local immune reactivity
M Rita I Young
Cancer Immunology, Immunotherapy : CII
|
November 25, 2003
Trials and tribulations of immunotherapy as a treatment option for patients with squamous cell carcinoma of the head and neck
M Rita I Young
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
May 16, 2008
Use of carcinogen-induced premalignant oral lesions in a dendritic cell-based vaccine to stimulate immune reactivity against both premalignant oral lesions and oral cancer
M Rita I Young
Angiogenesis
|
November 2, 2004
Tumor-derived prostaglandin E2 and transforming growth factor-beta stimulate endothelial cell motility through inhibition of protein phosphatase-2A and involvement of PTEN and phosphatidylinositide 3-kinase
M Rita I Young
International Journal of Cancer
|
March 3, 2004
Tumor skewing of CD34+ progenitor cell differentiation into endothelial cells
M Rita I Young
Trends in Cancer Research
|
October 30, 2018
Influence of vitamin D on cancer risk and treatment: Why the variability?
M Rita I Young, Ying Xiong
Page
of 8